SilicoLife Lda.
Latest round
- Series A
Last raised
- Dec 2022
Total raised
- $5.2M
Investors
- 1
About SilicoLife Lda.
Founded in 2010 and based in Braga, Portugal, SilicoLife Lda. operates as a biotechnology company that focuses on microorganisms and novel pathways using metabolic engineering and synthetic biology approaches. The company offers metabolic engineering and synthetic biology used to produce compounds such as chemicals, food ingredients, or biopolymers. The company designs biosynthetic pathways for both natural and unnatural compounds using engineered enzymes. Its methodology includes system biology, bioinformatics, artificial intelligence, text mining, and metabolic engineering.
Who invested in SilicoLife Lda.
1 investor across 1 round
See all investors in SilicoLife Lda.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 7, 2022
Amount
$5.2M
Investors
Questions about SilicoLife Lda.
Who invested in SilicoLife Lda.?
SilicoLife Lda. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SilicoLife Lda. raised?
SilicoLife Lda. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SilicoLife Lda. last raise money?
SilicoLife Lda.'s most recent round on record is a Series A, in Dec 2022.
What does SilicoLife Lda. do?
Founded in 2010 and based in Braga, Portugal, SilicoLife Lda.
Where is SilicoLife Lda. headquartered?
SilicoLife Lda. is headquartered in Portugal.
Which VCs invest in companies like SilicoLife Lda.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at SilicoLife Lda.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like SilicoLife Lda.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.